Nazli Dizman covers an update on the CBM588 probiotic strain and its phase II trial.
The Uromigos: Microbiome
Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news on the microbiome.
Advertisement
Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri.
The Uromigos and Monty Pal discuss data on microbiome modification's impact on immune-oncology clinical efficacy in mRCC.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.